✦ LIBER ✦

Liraglutide, a Once-daily Human GLP-1 Analog, In Type 2 Diabetes Provides Similar Glycemic Control with Reduced Body Weight Compared with Glimepiride when Added to Metformin.

✍ Scribed by Frid, A.; Nauck, M.A.; Hermansen, K.; Shah, N.S.; Tankova, T.; Mitha, I.H.; During, M.; Zdravkovic, M.; Matthews, D.

Book ID: 122247849
Publisher: Canadian Diabetes Association
Year: 2008
Tongue: English
Weight: 681 KB
Volume: 32
Category: Article
ISSN: 1499-2671
DOI: 10.1016/S1499-2671(08)24121-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liraglutide, a Once-daily Human GLP-1 An

Liraglutide, a Once-daily Human GLP-1 Analog, In Type 2 Diabetes Provides Similar Glycem1c Control with Reduced Body Weight Compared with Glimepiride when Added to Metformin.

✍ Frid, A.; Nauck, M.A.; Hermansen, K.; Shah, N.S.; Tankova, T.; Mitha, I.H.; Duri 📂 Article 📅 2008 🏛 Canadian Diabetes Association 🌐 English ⚖ 681 KB

Significantly Better Glycemic Control an

Significantly Better Glycemic Control and Weight Reduction with Liraglutide, a Once-Daily Human GLP- 1 Analog, Compared With Glimepiride: All as Monotherapy In Type 2 Diabetes.

✍ Garber, A.; Henry, R.; Ratner, R.; Garcia-Hernandez, P.; Rodriquez Pattzi, H.M.; 📂 Article 📅 2008 🏛 Canadian Diabetes Association 🌐 English ⚖ 701 KB

Significantly Better Glycemic Control an

Significantly Better Glycemic Control and Weight Reduction with Liraglutide, a Once-daily Human GLP-1 Analog, Compared with Insulin Glargine: All as Add-on to Metformin and a Sulfonylurea in Type 2 Diabetes.

✍ Schmitz, O.; Russell-Jones, D.; Vaag, A.; Sethi, B.K.; lalic, N.; Antic, S.; Zdr 📂 Article 📅 2008 🏛 Canadian Diabetes Association 🌐 English ⚖ 702 KB

Liraglutide, a once-daily human glucagon

Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes

✍ A. Garber; R. R. Henry; R. Ratner; P. Hale; C. T. Chang; B. Bode 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 971 KB

Liraglutide, a once-daily human GLP-1 an

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

✍ Marre, M. (author);Shaw, J. (author);Brändle, M. (author);Bebakar, W. M.W. (auth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB

Liraglutide, a once-daily human GLP-1 an

✍ Marre, M. (author);Shaw, J. (author);Brändle, M. (author);Bebakar, W. M.W. (auth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB